NO20010390L - Behandling av angstsykdommer - Google Patents
Behandling av angstsykdommerInfo
- Publication number
- NO20010390L NO20010390L NO20010390A NO20010390A NO20010390L NO 20010390 L NO20010390 L NO 20010390L NO 20010390 A NO20010390 A NO 20010390A NO 20010390 A NO20010390 A NO 20010390A NO 20010390 L NO20010390 L NO 20010390L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- anxiety disorders
- anatonist
- serotonin
- mammal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Abstract
Foreliggende oppfinnelse tilveiebringe: en fremgangsmåte for behandling eller forebygging ay angstforstyrrelser og omfatter administrering til et pattedyr med behov for en slik behandling av en effektiv mengde av en serotonin-5-HTiF-reseptor-anatgonist.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9431098P | 1998-07-27 | 1998-07-27 | |
PCT/US1999/015475 WO2000006082A2 (en) | 1998-07-27 | 1999-07-08 | Treatment of anxiety disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20010390D0 NO20010390D0 (no) | 2001-01-23 |
NO20010390L true NO20010390L (no) | 2001-03-13 |
Family
ID=22244420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010390A NO20010390L (no) | 1998-07-27 | 2001-01-23 | Behandling av angstsykdommer |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0976747A3 (no) |
JP (1) | JP2003527305A (no) |
KR (1) | KR20010072064A (no) |
CN (1) | CN1315830A (no) |
AU (1) | AU4977899A (no) |
BR (1) | BR9913348A (no) |
CA (1) | CA2338740A1 (no) |
EA (1) | EA200100182A1 (no) |
HU (1) | HUP0102886A3 (no) |
IL (1) | IL140540A0 (no) |
NO (1) | NO20010390L (no) |
PL (1) | PL366197A1 (no) |
TR (1) | TR200100240T2 (no) |
WO (1) | WO2000006082A2 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2259619T3 (es) * | 1999-12-20 | 2006-10-16 | Eli Lilly And Company | Derivados de indol para el tratamiento de depresion y ansiedad. |
AU2251801A (en) * | 1999-12-20 | 2001-07-03 | Eli Lilly And Company | Piperidine derivatives and their use as serotonin receptor antagonists |
AU2049601A (en) | 1999-12-20 | 2001-07-03 | Eli Lilly And Company | Benzofuran derivatives |
EP1853577A4 (en) * | 2005-02-17 | 2009-02-18 | Bayer Cropscience Ag | IMPROVED PROCESS FOR THE PREPARATION OF (DISUBSTITUTED PROPENYL) PHENYL ALKYL SUBSTITUTED DIHYDROBENZOFURANES |
WO2006088963A1 (en) * | 2005-02-17 | 2006-08-24 | Bayer Cropscience Ag | Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
WO2006102387A1 (en) * | 2005-03-23 | 2006-09-28 | Bayer Cropscience Ag | Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
CN107973766B (zh) * | 2016-10-21 | 2020-06-19 | 石家庄诚志永华显示材料有限公司 | 含有环烷基的氧芴衍生物的液晶化合物及其应用 |
TWI744458B (zh) * | 2017-02-27 | 2021-11-01 | 日商捷恩智股份有限公司 | 具有二苯并呋喃環的化合物、液晶組成物及液晶顯示元件 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2941597A1 (de) * | 1979-10-13 | 1981-04-23 | Basf Ag, 6700 Ludwigshafen | Piperidinderivate von 4,5-dialkyl-3-hydroxy-pyrrol-2-carbonsaeureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen |
GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
US5698571A (en) * | 1994-10-05 | 1997-12-16 | Eli Lilly And Company | 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
US5521197A (en) * | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
-
1999
- 1999-07-08 EA EA200100182A patent/EA200100182A1/ru unknown
- 1999-07-08 IL IL14054099A patent/IL140540A0/xx unknown
- 1999-07-08 WO PCT/US1999/015475 patent/WO2000006082A2/en not_active Application Discontinuation
- 1999-07-08 JP JP2000561939A patent/JP2003527305A/ja not_active Withdrawn
- 1999-07-08 HU HU0102886A patent/HUP0102886A3/hu unknown
- 1999-07-08 BR BR9913348-2A patent/BR9913348A/pt not_active Application Discontinuation
- 1999-07-08 PL PL99366197A patent/PL366197A1/xx not_active Application Discontinuation
- 1999-07-08 CN CN99809056A patent/CN1315830A/zh active Pending
- 1999-07-08 AU AU49778/99A patent/AU4977899A/en not_active Abandoned
- 1999-07-08 TR TR2001/00240T patent/TR200100240T2/xx unknown
- 1999-07-08 KR KR1020017001090A patent/KR20010072064A/ko not_active Application Discontinuation
- 1999-07-08 CA CA002338740A patent/CA2338740A1/en not_active Abandoned
- 1999-07-26 EP EP99305923A patent/EP0976747A3/en not_active Withdrawn
-
2001
- 2001-01-23 NO NO20010390A patent/NO20010390L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010072064A (ko) | 2001-07-31 |
TR200100240T2 (tr) | 2002-01-21 |
WO2000006082A3 (en) | 2000-05-04 |
PL366197A1 (en) | 2005-01-24 |
AU4977899A (en) | 2000-02-21 |
CA2338740A1 (en) | 2000-02-10 |
HUP0102886A3 (en) | 2002-12-28 |
BR9913348A (pt) | 2001-06-12 |
EA200100182A1 (ru) | 2001-08-27 |
WO2000006082A2 (en) | 2000-02-10 |
HUP0102886A2 (en) | 2002-06-29 |
NO20010390D0 (no) | 2001-01-23 |
EP0976747A3 (en) | 2000-09-13 |
IL140540A0 (en) | 2002-02-10 |
JP2003527305A (ja) | 2003-09-16 |
CN1315830A (zh) | 2001-10-03 |
EP0976747A2 (en) | 2000-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0867184T3 (da) | Anvendelse af tiagabin til behandling af søvnforstyrrelser | |
NO20010844L (no) | Regulering av substrataktivitet | |
DE60045751D1 (de) | Therapeutische Behandlung androgenrezeptorbedingter Leiden | |
NO20013155L (no) | Fremgangsmate ved anvendelse av cyklooksygenase-2-inhibitor og ett eller flere antineoplastiske midler som enkombinasjonsterapi i behandlingen av neoplasi | |
ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
DE69729125D1 (de) | Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese | |
DE59601624D1 (de) | Verwendung von 2-amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzen zur prophylaxe und behandlung der folgen der akuten und chronischen zerebralen minderdurchblutung sowie neurodegenerativer erkrankungen | |
DK1140181T3 (da) | Konbinationsterapi af bestråling og en COX-2-inhibitor til behandling af neoplasi | |
DK0723444T3 (da) | Levobupivacain, som er egnet til behandling af kronisk smerte | |
DE60008753D1 (de) | Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen | |
NO20010390L (no) | Behandling av angstsykdommer | |
DE69426471D1 (de) | Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie | |
SE9603725D0 (sv) | New teatment | |
KR890701099A (ko) | 기침 및 기관지 협착을 치료하기 위한 5-ht3 수용기 길항물질 | |
NO984446L (no) | FremgangsmÕte for behandling av smerte | |
DE69928244D1 (de) | Inhibitoren der nf-kb aktivierung | |
NO984160L (no) | FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt | |
NO984197L (no) | FremgangsmÕte for behandling av autisme | |
MXPA02004699A (es) | Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco. | |
ATE369143T1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
ATE306278T1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
NO984196D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
NO984198L (no) | FremgangsmÕte for behandling av aggresjon | |
UA36485A (uk) | Спосіб лікування генералізованого пародонтиту | |
UA10439A (uk) | Спосіб лікуваhhя запальhих та алергійhих захворюваhь hоса, hосоглотки та вуха |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |